Trinity Biotech (TRIB) EBT (2016 - 2024)
Historic EBT for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$15.8 million.
- Trinity Biotech's EBT fell 18695.73% to -$15.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$30.7 million, marking a year-over-year increase of 1679.57%. This contributed to the annual value of -$30.7 million for FY2024, which is 1678.18% up from last year.
- Latest data reveals that Trinity Biotech reported EBT of -$15.8 million as of Q4 2024, which was down 18695.73% from -$4.8 million recorded in Q3 2024.
- In the past 5 years, Trinity Biotech's EBT registered a high of $10.3 million during Q3 2020, and its lowest value of -$18.6 million during Q2 2023.
- Moreover, its 5-year median value for EBT was -$5.1 million (2023), whereas its average is -$4.1 million.
- Its EBT has fluctuated over the past 5 years, first skyrocketed by 28689.45% in 2020, then crashed by 782968.75% in 2022.
- Quarter analysis of 5 years shows Trinity Biotech's EBT stood at $10.3 million in 2020, then plummeted by 123.6% to -$2.4 million in 2021, then crashed by 329.53% to -$10.4 million in 2022, then skyrocketed by 47.21% to -$5.5 million in 2023, then plummeted by 186.96% to -$15.8 million in 2024.
- Its EBT was -$15.8 million in Q4 2024, compared to -$4.8 million in Q3 2024 and -$6.9 million in Q2 2024.